Drug
Naproxen-n-butyl nitrate clinical trials
Also written naproxcinod.
How studies write it
Studies that test it under each name
Studies by the year they started
9 studies that test it; most in 2008 (4)
| Year | Studies |
|---|---|
| 2005 | 1 |
| 2007 | 2 |
| 2008 | 4 |
| 2009 | 1 |
| 2010 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 9 · Other 0
NicOx (9)
Often tested with
Tested in the same studies.
Related medicines
As reviewed, each with the page that says it.
- One of Cyclooxygenase Inhibitors source
Studies
Open first, then newest update. How each study uses naproxen-n-butyl nitrate is read from its arms, and is right about nine times in ten.
Testing it · 9
- Pharmacokinetics Study: Determination of Naproxcinod and Its Metabolites After Oral Administration in MaleCompletedPhase 1NicOxNCT01404598Written as naproxcinod 3000 mg od
- Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the KneeCompletedPhase 3NicOxNCT00504127Written as Naproxcinod 375 mg bid
- To Assess the Effect of Naproxcinod Versus Naproxen and Ibuprofen on Arterial Blood Pressure in Osteoarthritis Patients With Controlled Essential HypertensionCompletedPhase 1NicOxNCT00662896Written as naproxcinod 375 mg bid
- A Phase 1 Study to Compare the PK and Safety of Naproxcinod in Hepatic Impaired Patients and Matching Healthy SubjectsCompletedPhase 1NicOxNCT00621881Written as naproxcinod
- A Study to Assess the Effects of Naproxcinod and Naproxen on Blood Pressure Measurements in Osteoarthritis Patients With Controlled High Blood PressureCompletedPhase 1NicOxNCT00662610Written as naproxcinod 375 mg -750 mg -1125 mg bid
- Effect of Repeated Dosing of Naproxcinod on Renal Hemodynamic and on Sodium Balance in Healthy Volunteers Before and After a Single Dose of FurosemideCompletedPhase 1NicOxNCT00909519Written as naproxcinod
- Analgesic Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the KneeCompletedPhase 3NicOxNCT00542555Written as Naproxcinod 375 mg
- Efficacy and Safety Study of Naproxcinod in Subjects With Osteoarthritis of the HipCompletedPhase 3NicOxNCT00541489Written as Naproxcinod
- A Pharmacokinetics and Safety Study of Naproxcinod in Subjects With Impaired Renal FunctionCompletedPhase 1NicOxNCT00674856Written as naproxcinod
Codes
What other systems call naproxen-n-butyl nitrate · ClinicalTrials.gg INT004065
- MeSH (NLM) C111751naproxen-n-butyl nitrateOne source ClinicalTrials.gov
- UNII (FDA) V24GR4LI3INAPROXCINODConfirmed FDA, NLM
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C111751 | naproxen-n-butyl nitrate | One source ClinicalTrials.gov |
| UNII (FDA) | V24GR4LI3I | NAPROXCINOD | Confirmed FDA, NLM |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.